[HTML][HTML] Spatially fractionated radiation therapy: History, present and the future

W Yan, MK Khan, X Wu, CB Simone II, J Fan… - Clinical and translational …, 2020 - Elsevier
Spatially Fractionated Radiation therapy (SFRT) has a history of over 100 years. The
principle of SFRT is distinctive from the standard radiation approaches, as it treats the total …

Update on image-guided thermal lung ablation: society guidelines, therapeutic alternatives, and postablation imaging findings

MC Murphy, MM Wrobel, DA Fisher… - American Journal of …, 2022 - Am Roentgen Ray Soc
Percutaneous image-guided thermal ablation (IGTA) has been endorsed by multiple
societies as a safe and effective lung-preserving treatment of primary lung cancer and …

Interventional bronchoscopy

GJ Criner, R Eberhardt, S Fernandez-Bussy… - American journal of …, 2020 - atsjournals.org
For over 150 years, bronchoscopy, especially flexible bronchoscopy, has been a mainstay
for airway inspection, the diagnosis of airway lesions, therapeutic aspiration of airway …

Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?

V Moiseenko, J Zhao, MT Milano, L Li, A Rimner… - International Journal of …, 2021 - Elsevier
Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …

Expanded HILUS trial: a pooled analysis of risk factors for toxicity from stereotactic body radiation therapy of central and ultracentral lung tumors

S Lindberg, V Grozman, K Karlsson, E Onjukka… - International Journal of …, 2023 - Elsevier
Purpose Stereotactic body radiation therapy for tumors near the central airways implies high-
grade toxic effects, as concluded from the HILUS trial. However, the small sample size and …

[HTML][HTML] Squamous cell lung cancer

BR Sabbula, DP Gasalberti, F Anjum - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives:< p> Identify the etiology of squamous cell lung cancer.</p>< p> Review the
appropriate history, physical, and evaluation of squamous cell lung cancer.</p>< p> Outline …

[HTML][HTML] Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis

P Laeseke, C Ng, N Ferko, A Naghi, GWJ Wright… - Lung cancer, 2023 - Elsevier
Rationale Stereotactic body radiation therapy (SBRT) is the standard of care for inoperable
early stage non-small cell lung cancer (NSCLC). Use of image guided thermal ablation …

AIRO Breast Cancer Group Best Clinical Practice 2022 Update

A Ciabattoni, F Gregucci, F De Rose… - Tumori …, 2022 - journals.sagepub.com
Introduction: Breast cancer is the most common tumor in women and represents the leading
cause of cancer death. Radiation therapy plays a key-role in the treatment of all breast …

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study

H Horinouchi, S Atagi, S Oizumi, K Ohashi… - Cancer …, 2020 - Wiley Online Library
There are limited real‐world data on the treatment practices, outcomes, and safety of
chemoradiotherapy (CRT) alone in potential candidates for immune checkpoint inhibitors …

[HTML][HTML] The evolving toxicity profile of SBRT for lung cancer

M Thompson, KE Rosenzweig - Translational lung cancer research, 2019 - ncbi.nlm.nih.gov
Stereotactic body radiation therapy (SBRT) is an effective and well tolerated treatment for
early stage non-small cell lung cancer (NSCLC). The high doses used in thoracic SBRT can …